LEAVING OUR WEBSITE

You are now leaving our website.
Kindly note that this link is offered as a service and EVER is not responsible for any content published on the thirds-party website you are about to enter.

Cerebrolysin - General information
  • Home
  • Cerebrolysin®
    • About Cerebrolysin®
    • Safety
    • Mode of Action
    • Prescribing Information
    • Administration
    • FAQs
    • Download Area
  • Stroke
    • Disease
    • Clinical Efficacy
    • Administration
    • Expert Interviews
    • Rehabilitation
    • Trainings
    • Download Area
  • Dementia
    • Disease
    • Clinical Efficacy
    • Administration
    • Download Area
  • TBI
    • Disease
    • Clinical Efficacy
    • Administration
    • Expert Interviews
    • Download Area
  • News
  • Links
  • Search
     
Cerebrolysin®
  • About Cerebrolysin®
  • Safety
  • Mode of Action
  • Prescribing Information
  • Administration
  • FAQs
  • Download Area
  1. Cerebrolysin®
  2. Download Area

Download area Cerebrolysin®

General Cerebrolysin® Information

Dosage Card
Dosage CardInformation about dosage and administration705 KB
Introduction folder
Introduction folderThis brochure gives you an overview about Cerebrolysin®957 KB
Mode of Action Folder
Mode of Action FolderInformation about Mode of Action of Cerebrolysin®3 MB

> Cerebrolysin® Stroke Downloads

> Cerebrolysin® Dementia Downloads

> Cerebrolysin® TBI Downloads

Products
  • Imprint
  • Disclaimer
  • Data Privacy
  • Terms of Use
  • Sitemap
  • Adverse Events
  • Contact

© 2021 EVER Neuro Pharma GmbH

To access the site for information on Cerebrolysin® please confirm that you are a healthcare professional.

No, I am not a healthcare professional